Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -149,291 | -97,505 | -54,923 | -24,968 | -59,437 |
| Depreciation Amortization | 3,668 | 2,590 | 1,633 | 730 | 776 |
| Accounts payable and accrued liabilities | 13,702 | 7,675 | 2,842 | 1,869 | 8,567 |
| Other Working Capital | 9,256 | -8,081 | -19,129 | 2,200 | 5,112 |
| Other Operating Activity | 3,102 | 3,826 | 5,034 | 1,776 | -1,526 |
| Operating Cash Flow | $-119,563 | $-91,495 | $-64,543 | $-18,393 | $-46,508 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -236,721 | -208,207 | -156,562 | -132,186 | -44,500 |
| PPE Investments | -3,618 | -1,628 | -747 | -9 | -1,161 |
| Purchase Of Investment | 98,010 | 72,178 | 22,500 | 3,820 | N/A |
| Sale Of Investment | 4,437 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-137,892 | $-137,657 | $-134,809 | $-128,375 | $-45,661 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 9,936 |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,000 |
| Common Stock Issued | 157,821 | 157,732 | 157,275 | 157,250 | 246,418 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 134,336 |
| Financing Cash Flow | $157,821 | $157,732 | $157,275 | $157,250 | $380,690 |
| Beginning Cash Position | 303,153 | 303,153 | 303,153 | 303,153 | 14,632 |
| End Cash Position | 203,519 | 231,733 | 261,076 | 313,635 | 303,153 |
| Net Cash Flow | $-99,634 | $-71,420 | $-42,077 | $10,482 | $288,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,563 | -91,495 | -64,543 | -18,393 | -46,508 |
| Capital Expenditure | -3,618 | -1,628 | -747 | -9 | -1,161 |
| Free Cash Flow | -123,181 | -93,123 | -65,290 | -18,402 | -47,669 |